drug

Documents about drug

• A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin#184814ClinicalTrials.gov
• Harm reduction and drug policy: implications for South Africa#260298OpenUCT
• Metformin and Furosemide Drug-Drug Interaction Study#238297ClinicalTrials.gov
• Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects#148704ClinicalTrials.gov
• Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin#127823ClinicalTrials.gov
• Analysis of drug-drug interactions between psychiatric drugs in spontaneous adverse drug reaction reports from EudraVigilance.#165666NCBI PubMed Central
• Principles of early drug discovery#6669OpenAlex
• Retrospective longitudinal drug utilization study of medicines for anxiety disorders in Bulgaria#245149ARPHA OAI-PMH Endpoint
• A DDI Study of JMKX000623 and Metformin Hydrochloride#208391ClinicalTrials.gov
• A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone#261464ClinicalTrials.gov
• FSSM-DDI: Fusion State Space Model for predicting drug-drug interaction using social-media and drug descriptions.#255238NCBI PubMed Central
• Drug-drug Interaction Study With Metformin and Imatinib#158185ClinicalTrials.gov
• Drug-Drug Interaction Study of Atumelnant in Healthy Participants#180345ClinicalTrials.gov
• Governing families: State discourses and professional practices in the making of Irish drug policy 1971–2016#186692ULRR
• Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery#67570Europe PMC
• Recent Trends in Electrospun Nanofibers for Drug Delivery Systems in Asia#194519Indonesian Journal of Pharmacy
• Operational planning of the SECURE initiative to improve access to essential antibiotics: meeting report, 27 June 2024#203867WHO IRIS
• Patterns of drug-prescribed and drug-related problems among hospitalized elderly patients#74375PhilArchive
• Flucloxacillin as an Inducer of CYP-enzymes#121417ClinicalTrials.gov
• Development of an adverse drug event network to predict drug toxicity#179438HAL (France)
• Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B#261403ClinicalTrials.gov
• Transforming the paediatric medicines ecosystem: strategic roadmap 2025-2030#216369WHO IRIS
• Subregional networks of antimalaria drug efficacy and resistance in Eastern Africa and Horn of Africa countries: meeting report, Kampala, Uganda, 9-10 November 2023#225751WHO IRIS
• Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis#215773OpenAlex
• Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics#146393ClinicalTrials.gov
• Mechanisms of drug-drug interaction between rifampicin and fusidic acid#156406HAL (France)
• Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants#175080ClinicalTrials.gov
• The re-emergence of natural products for drug discovery in the genomics era#10516OpenAlex
• WHO Drug Information 2025, vol. 39, 4 [full issue]#133936WHO IRIS
• WHO Drug Information 2025, vol. 39, 1 [full issue]#166326WHO IRIS
• The Effect of Dicloxacillin on Oral Absorption of Drugs#180423ClinicalTrials.gov
• A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance#219319Ora Oxford University Research
• Microbiota as a modulator of drug response: targeting microbial-drug crosstalk in cancer therapy#120198Europe PMC
• Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir#136254ClinicalTrials.gov
• Rethinking Mandated Drug Treatment: Why Expanding Freedom Requires Structural Drug Policy Reform.#159615NCBI PubMed Central
• Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants#184799ClinicalTrials.gov
• Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects#226310ClinicalTrials.gov
• Toxicity of nanostructures in drug delivery applications#4483Europe PMC
• Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib#121321ClinicalTrials.gov
• Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction of Pyrimethamine and Metformin IR#158181ClinicalTrials.gov
• Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults#162442ClinicalTrials.gov
• Interaction between host genetics and drug therapy in influencing gut bacterial diversity#196979OpenUCT
• Table 4_Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights.docx#192994Figshare
• Table 1_Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights.docx#192996Figshare
• Table 2_Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights.docx#192997Figshare
• Table 3_Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights.docx#192998Figshare
• Image 3_Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights.tif#192999Figshare
• Image 4_Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights.tif#193000Figshare
• Image 1_Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights.tif#193001Figshare
• Image 2_Drug-coated balloons vs. drug-eluting stents for coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials with lesion-specific insights.tif#193002Figshare

Related topics